Other
Journal
About P&T Journal
Contacts:Editor:
ssherritze@medimedia.com
Advertising:
mliberti@medimedia.com
Circulation:
lgardineer@medimedia.com
Production:
wpeart@medimedia.com
Rate Card
Production Specifications
Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints
Recent Issues
December 2011
Features
Health Care and Law
Applying Legal Risk Management to the Clinical Use of Methadone
Methadone is gaining renewed interested as a therapy for chronic pain as well as for opioid dependence. The authors discuss safety concerns, two legal cases that resulted from patients’ deaths, and risk–management issues for P&T committees to consider.
James O’Donnell, PharmD, MS; and F. Randy Vogenberg, RPh, PhD
Meeting Highlights
62nd Annual Meeting of the American Association For the Study of Liver Diseases and American College of Rheumatology Annual Meeting
Topics covered at "Liver Week" included alisporivir and a protease inhibitor (BI 201335) for hepatitis C virus infection; everolimus for liver transplantation, and telaprevir in cirrhosis. The rheumatology sessions addressed the small molecule apremilast for psoriatic arthritis; etanercept for rheumatoid arthritis; and abatacept, adalimumab, etanercept, and infliximab in rheumatoid arthritis.
Walter Alexander
P&T Snapshot
A Survey of Oncology Trends
The Oncologist's Perspective
New findings reveal that patients with breast, prostate, and colon cancers are increasingly being treated in outpatient settings instead of hospitals; most cancer patients have early-stage disease upon diagnosis, except for Medicaid recipients; and oncologists have concerns about decreasing net profits.
Janice Zoeller and Peter Sonnenreich, MA
Continuing Education Credit
Newer Oral Atypical Antipsychotic Agents: A Review
Four second-generation antipsychotic medications — paliperidone (Invega), iloperidone (Fanapt), asenapine (Saphris), and lurasidone (Latuda) — may offer useful options for patients with schizophrenia, schizoaffective disorder, and bipolar disorder as well as depression.
Jonathan R. Scarff, MD; and David A. Casey, MD
Season’s Greetings
Thank you to our readers and reviewers
Departments
Medication Errors
Including Patients on Root Cause Analysis Teams: Pros and Cons
Matthew Grissinger, RPh, FASCP
Prescription: Washington
Final Rule on ACOs Raises Concerns About Medication Cost-Shifting
Pharmacists to Play a Secondary Role in New Physician–Hospital Organizations
Hospital pharmacists will be dealing with the fallout from cost-shifting in ACOs — with none of the benefits
Stephen Barlas
New Drugs/Drug News/New Medical Devices
FDA approvals, drug indications, and updates
Pharmaceutical Approval Update
Deferiprone (Ferriprox) for iron overload after blood transfusions; and ezogabine (Potiga) for partial-onset seizures
Marvin M. Goldenberg, PhD, RPh, MS
Drug Forecast
Efficacy and Safety of Linagliptin (Tradjenta) in Adults With Type-2 Diabetes Mellitus
Linagliptin (Tradjenta) for type-2 diabetes mellitus
Maisha Kelly Freeman, PharmD, MS, BCPS
